Search

Author/Creator Severance, Randall

1. Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trial. (January 2016)

Authors:
Farnier, Michel; Jones, Peter; Severance, Randall; Averna, Maurizio; Steinhagen-Thiessen, Elisabeth; Colhoun, Helen M.; Du, Yunling; Hanotin, Corinne; Donahue, Stephen
Journal:
Atherosclerosis
Issue:
Volume 244(2016)
Page Start:
138
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study. Issue 11 (2nd November 2018)

Authors:
Abu-Elyazeed, Remon; Jennings, William; Severance, Randall; Noss, Michael; Caplanusi, Adrian; Povey, Michael; Henry, Ouzama
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 14:Issue 11(2018)
Page Start:
2624
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults. Issue 5 (29th January 2018)

Authors:
Adams, Michael; Bolshoun, David; Bruce, Tami; Chuang, Rita; DeSantis, Donna; Fiel, Thomas; Fitzgibbons, William; Francyk, David; Geisberg, Harry; Giep, Son; Godbole, Narendra; Haas, Terry; Halpern, Stephen; Inzerello, Anthony; Jennings, William; Kaiser, Scott; Kay, Jennifer; Kirby, William; Lendi...
Journal:
Vaccine
Issue:
Volume 36:Issue 5(2018)
Page Start:
668
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study. Issue 5 (May 2022)

Authors:
Sridhar, Saranya; Joaquin, Arnel; Bonaparte, Matthew I; Bueso, Agustin; Chabanon, Anne-Laure; Chen, Aiying; Chicz, Roman M; Diemert, David; Essink, Brandon J; Fu, Bo; Grunenberg, Nicole A; Janosczyk, Helene; Keefer, Michael C; Rivera M, Doris M; Meng, Ya; Michael, Nelson L; Munsiff, Sonal S; Ogbu...
Journal:
Lancet infectious diseases
Issue:
Volume 22:Issue 5(2022)
Page Start:
636
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU). Issue 1 (31st December 2022)

Authors:
Severance, Randall; Schwartz, Howard; Dagan, Ron; Connor, Laurie; Li, Jianing; Pedley, Alison; Hartzel, Jonathan; Sterling, Tina M.; Nolan, Katrina M.; Tamms, Gretchen M.; Musey, Luwy K.; Buchwald, Ulrike K.
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 18:Issue 1(2022)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU). Issue 1 (31st January 2022)

Authors:
Severance, Randall; Schwartz, Howard; Dagan, Ron; Connor, Laurie; Li, Jianing; Pedley, Alison; Hartzel, Jonathan; Sterling, Tina M.; Nolan, Katrina M.; Tamms, Gretchen M.; Musey, Luwy K.; Buchwald, Ulrike K.
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 18:Issue 1(2022)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗